Skip to content

Comparison of efficacy and safety between fospropofol disodium, remimazolam and propofol for general anesthesia induction in elderly patients

Comparison of efficacy and safety between fospropofol disodium, remimazolam and propofol for general anesthesia induction in elderly patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122755
Enrollment
Unknown
Registered
2026-04-17
Start date
2026-05-19
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia induction of elderly patients

Interventions

Remimazolam group:Anesthesia induction was performed with remimazolam at a dose of 0.2~0.3 mg/kg, administered by intravenous bolus injection within 1 minute.
Propofol group:Anesthesia induction was performed with propofol at a dose of 1~2 mg/kg, administered by intravenous bolus injection within 1 minute.
Fospropofol disodium group:Anesthesia induction was performed with fospropofol disodium at a dose of 10~12 mg/kg, administered by intravenous bolus injection within 1 minute.

Sponsors

The First People’s Hospital of Jingzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 60 years, gender not limited, with American Society of Anesthesiologists (ASA) physical status classification of grade ? to ?. 2. Body mass index (BMI) ranged from 18.5 to 30 kg/m²; 3. Scheduled for elective general anesthesia with the expected duration of surgery more than 30 minutes. 4. Clear consciousness before surgery and able to cooperate with the completion of basic assessments. 5. Patients and their family members provided informed consent and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Scheduled to undergo cardiac surgery, craniocerebral surgery, burn surgery or interventional surgery. 2. A history of severe heart, brain, lung, liver, kidney and metabolic diseases. 3. Unable to receive bispectral index (BIS) monitoring. 4. A history of allergy to general anesthetics such as remimazolam and propofol; 5. Patients with difficult airway. 6. Patients with uncontrolled hypertension and diabetes mellitus. 7. Currently participating in another interventional study. 8. Suspected of abusing narcotic analgesics or sedatives. 9. Pregnant or lactating women. 10. Patients with neuromuscular system diseases or mental illnesses.

Design outcomes

Primary

MeasureTime frame
Incidence of hypotension during anesthesia induction;

Secondary

MeasureTime frame
Hemodynamic changes during anesthesia induction;Duration of anesthetic intubation;Duration of successful anesthesia induction;Adverse reactions;

Countries

China

Contacts

Public ContactLi Tang

The First People’s Hospital of Jingzhou

462244408@qq.com+86 716 811 3627

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026